tirzepatide and semaglutide together vs Semaglutide: 2026 Clinical Comparison Semaglutide vs Tirzepatide: Weight Loss,

If you experience a suspected side effect from retatrutide within a trial, this should be reported through the trial's pharmacovigilance process

And it delivers: 16.7% average weight loss in 12 months Achieved using 66% less GLP-1 medication than industry norms 8 out of 10 members transition off meds without regaining weight That means lower total cost of care, reduced long-term pharmacy spend, fewer relapses and yo-yo dieting, and better employee satisfaction and retention

Individual results vary significantly based on diet, exercise, genetics, and metabolic factors

doi: 10.1111/nmo.12421 14 CamilleriM.VijayvargiyaP

We're working on it

Younossi ZM, Kalligeros M, Henry L